Lead exposure and multiple sclerosis study
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at whether lead exposure is linked to multiple sclerosis. It compares lead levels in people with MS and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 50 years old
- You have been diagnosed with multiple sclerosis based on the McDonald criteria
- You do not have any other autoimmune disease
- You do not have chronic kidney or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genes and life exposures may relate to developing multiple sclerosis (MS) or to MS itself. You may be invited if you have a specific connection to MS or certain past immune-related treatments.
This study follows people with multiple sclerosis to learn more about the disease and how it affects overall health. Researchers will collect information about your symptoms, treatments, and health outcomes over time to better understand MS and improve care.
This study follows people with multiple sclerosis (MS) and some healthy people in the local area to better understand MS and related nerve conditions. It may help researchers learn which symptoms and scan changes show up over time.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
This trial is studying how multiple sclerosis (MS) progresses over time. It may help researchers understand the disease better.
This trial is looking at how people with multiple sclerosis experience clinical study enrollment and participation. It may help improve how future MS trials work and are explained, especially for different types of participants.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.